1. Home
  2. Research and Funding
  3. Technology Advancement & Transfer
  4. Research Materials & Licensing
  5. Triazole Derivatives of 4,7-disubstituted 2 naphthoic acid (PPTN) as P2Y14 Receptor Antagonists

Triazole Derivatives of 4,7-disubstituted 2 naphthoic acid (PPTN) as P2Y14 Receptor Antagonists

Disclosed are novel small molecules that serve as potent and selective antagonist ligands of the P2Y14 receptor for UDP-glucose, which is a G protein-coupled receptor (GPCR). Blocking this receptor has been shown to be useful in models of asthma, diabetes, acute kidney injury and other conditions.

Resource Details

https://www.ott.nih.gov/technology/e-213-2015-0

tao@niddk.nih.gov

E-213-2015-0

Share